Cardiovascular Diagnostics Inc.
13Patents
1Active
13Granted
33Portfolio score
Filing activity: Apr 3, 1987 → Feb 16, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4849340A | Reaction system element and method for performing prothrombin time assay | Emerging Cross-Sectional Technologies | 290 | Expired |
| US5110727A | Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles | Emerging Cross-Sectional Technologies | 99 | Expired |
| US6197494A | Apparatus for performing assays on liquid samples accurately, rapidly and simply | Emerging Cross-Sectional Technologies | 93 | Expired |
| US5658723A | Immunoassay system using forced convection currents | Emerging Cross-Sectional Technologies | 86 | Expired |
| US5677133A | Dry chemistry cascade immunoassay and affinity assay | Emerging Cross-Sectional Technologies | 73 | Expired |
| US5350676A | Method for performing fibrinogen assays using dry chemical reagents containing magnetic particles | Physics | 66 | Expired |
| US5670329A | Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field | Physics | 54 | Expired |
| US5508521A | Method and apparatus for detecting liquid presence on a reflecting surface using modulated light | Physics | 34 | Expired |
| US5601991A | Dry chemistry cascade immunoassay and affinity assay | Emerging Cross-Sectional Technologies | 27 | Expired |
| US6165795A | Methods for performing fibrinogen assays using dry chemical reagents containing ecarin and magnetic particles | Emerging Cross-Sectional Technologies | 20 | Expired |
| USD501678S1 | Assay card for an assay chamber | General | 10 | Expired |
| US6680177B2 | Low molecular weight heparin assay, system and reagent therefor | Emerging Cross-Sectional Technologies | 4 | Expired |
| US12201517B2 | Transcatheter heart valve apparatus for calcific mitral stenosis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.